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NANOPARTICLES BASED ON HYDROXYPROPYLCYCLODEXTRYN: 
PREPARATION AND IN VITRO VIABILITY STUDY ON CACO2 CELLS
Spada G  . , Gavini E., Rassu G., De Candia G.M., Juliano C., Giunchedi P.
Dipartimento Scienze del Farmaco, Università degli Studi di Sassari, via Muroni 23/a, 
07100 Sassari, Italia
Cyclodextrins  (CDs)  are  cyclic  α-(1-4)-linked  oligosaccharides  of  α-D-glucopyranose  [1].  β-
Cyclodextrin is the most accessible, the lowest-priced and generally the most useful of parent 
cyclodextrins. Apart from these naturally occurring cyclodextrins, many cyclodextrin derivatives 
have been synthesised [2].
The main interest  in cyclodextrins lies in their ability to form solid inclusion complexes with 
several compounds [3], by a molecular complexation. There are numerous applications for CDs in 
the pharmaceuticals field, such as excipients [2], owing to the low ability of CDs to pass through 
biological  membranes  [4]. The  β-cyclodextrins  increase  the  drug  solubility  enhancing  the 
bioavailability of insoluble drugs, increase drug permeability of water-soluble drugs by direct 
action  on  mucosal  membranes  and  thus  they  are  considered  as  penetration  enhancers  [5,6]. 
Recently, CDs have also been studied for use as potential therapeutic agents; in particularly, their 
effects  on the CNS have been examined.  Camargo  et  al.  tested  the  use of  hydroxypropyl-β-
cyclodextrin  (HP)  against  Niemann-Pick  type  C,  which  is  a  neurogenerative  disorder 
characterised by greatly altered somatic cholesterol metabolism. Treatment with HP in a mouse 
model had moderate effect in delaying neurological symptoms and in decreasing liver cholesterol 
storage [7]. Moreover, CDs were presented as a new ideal class of antiprion compound due to 
their ability to reduce to undetectable levels the pathogenic isoform of the abnormal prion protein 
This antiprion activity is dependent on the size of the cyclodextrin [8]. 
The work purpose was to prepare and  in vitro characterise solid nanoparticles based on HP by 
high pressure emulsification method; the effect on the viability of the formulations on Caco2 cells 
has been also evaluated.
A  series  of  W/O  emulsions  named  HPO1-HPO6  has  been  set  using  the  High-Pressure 
Homogenizer "Panda NS100L".  
Manufacturing parameters such as water-oil ratios, amount of HP and pressures of emulsification 
have been studied aiming for the most stable nanoemulsion which has been dried to obtain solid 
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nanoparticles. Size characterization of both emulsions and solid nanoparticles has been performed 
by  laser diffraction spectroscopy. Morphology of nanoparticles has been observed by  Scanning 
Electron Microscopy (SEM). Cytotoxicity of HPO6 formulation at different concentrations has 
been assessed after 24 hours on Caco2 cells by using the reduction of MTT reagent.
Parameters employed for the preparation of the formulation HPO6 resulted suitable to obtain a 
stable and homogeneous nanoemulsion being Mean Diameter and Polydispersivity Index of about 
360 nm and 1.0, respectively. The exsiccation process of nanoemulsion determines an increase of 
particle  size  which  resulted  anyway  in  the  nano  size  order.  The  dried  particles  of  HPO6s 
morphologically analyzed by SEM, show nanoparticles with smooth surface but not completely 
shaped.
HPO6 displayed concentration-dependent cytotoxicity towards Caco2 cells. However this effect 
has been ascribed to the residue of surfactant: 100% of cell viability has been found by avoiding 
the presence of the surfactant
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